Litcius/Paper detail

4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial

Peter Hoskin, B. Popova, Oliver Schofield, Caroline Brammer, Martin Robinson, Adrian Murray Brunt, Krishnaswamy Madhavan, Tim Illidge, Eve Gallop‐Evans, Isabel Syndikus, Laura Clifton‐Hadley, Amy A. Kirkwood

2021The Lancet Oncology108 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRadiation therapyAdverse effectFollicular lymphomaClinical endpointRandomized controlled trialLymphomaSurgeryInternal medicineLymphoma Diagnosis and TreatmentCutaneous lymphoproliferative disorders researchOvarian cancer diagnosis and treatment
4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial | Litcius